Christine G. Ocampo
2017
In 2017, Christine G. Ocampo earned a total compensation of $308.2K as Former Chief Financial Officer at Tokai Pharmaceuticals.
Compensation breakdown
| Bonus | $80,000 |
|---|---|
| Option Awards | $139,219 |
| Salary | $60,808 |
| Other | $28,220 |
| Total | $308,247 |
Ocampo received $139.2K in option awards, accounting for 45% of the total pay in 2017.
Ocampo also received $80K in bonus, $60.8K in salary and $28.2K in other compensation.
Rankings
In 2017, Christine G. Ocampo's compensation ranked 13,282nd out of 14,666 executives tracked by ExecPay. In other words, Ocampo earned more than 9.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,282 out of 14,666 | 9th |
Division Manufacturing | 5,223 out of 5,770 | 10th |
Major group Chemicals And Allied Products | 1,891 out of 2,074 | 9th |
Industry group Drugs | 1,576 out of 1,730 | 9th |
Industry Pharmaceutical Preparations | 1,213 out of 1,329 | 9th |
Source: SEC filing on April 30, 2018.
Ocampo's colleagues
We found five more compensation records of executives who worked with Christine G. Ocampo at Tokai Pharmaceuticals in 2017.
2017
Gregory Flesher
Tokai Pharmaceuticals
Chief Executive Officer
2017
Jodie Morrison
Tokai Pharmaceuticals
Chief Executive Officer
2017
John McBride
Tokai Pharmaceuticals
Chief Financial Officer
2017
Catherine Turkel
Tokai Pharmaceuticals
President
2017
Jon Kuwahara
Tokai Pharmaceuticals